Molecular and Clinical Portrait of HER2-low Invasive Lobular Carcinomas

Invasive lobular carcinomas (ILCs) have a low frequency of ERBB2 amplification, therefore restricting the use of conventional anti-HER2 therapies for this histologic special type. Conversely, ILCs with low HER2 overexpression may represent a broader target for the use of emerging antibody drug conju...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Modern pathology 2024-05, Vol.37 (5), p.100463, Article 100463
Hauptverfasser:	Djerroudi, Lounes, El Sabeh-Ayoun, Ahmad, Benoist, Camille, Pierron, Gaelle, Masliah-Planchon, Julien, Fuhrmann, Laetitia, Kieffer, Yann, Carton, Matthieu, Ramtohul, Toulsie, Callens, Celine, Renault, Victor, Bidard, François-Clément, Mechta-Grigoriou, Fatima, Vincent-Salomon, Anne
Format:	Artikel
Sprache:	eng
Schlagworte:	breast cancer ERBB3 mutation HER2-low human epidermal growth factor receptor 2 (HER2) status invasive lobular carcinoma Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!